Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Assessment of Childhood Immunisation Services in Kano and Lagos States, Nigeria: A Mixed-methods Study.
Salaudeen, AG; Bolarinwa, OA; MCGOWAN, CR; Daniel, D; ALHAFFAR, M; ABBAS, K; Adesoro, O; Ahmed, T; Clarke, A; Makunja, S; ABDELMAGID, N; Akande, TM;
2026
Health Services Insights, (2026).19, 10.1177/11786329261477836.
Global vaccine readiness: equity-by-design in pandemic preparedness and response.
Ghafari, M; Watson, OJ; Dascalu, S; Mon, SH H; Abeler-Dörner, L; Rezaee-Zavareh, MS; Pley, C; Kordasti, S; ABBAS, K; Madani, K; Panovska-Griffiths, J;
2026
Expert review of vaccines, (2026).25 1 10.1080/14760584.2026.2732508.
Projections of human papillomavirus (HPV) vaccination impact on non-cervical cancer outcomes among women in 117 low- and middle-income countries: a modelling study.
Tuli, A; Jit, M; ABBAS, K; Portnoy, A;
2026
BMJ Global Health, (2026).11 8 10.1136/bmjgh-2025-021127.
Estimating the basic reproduction number of measles in low-and middle-income settings using 172 seroprevalence studies: A modelling approach.
FU, H; Sbarra, AN; Russell, T; ABBAS, K; Auzenbergs, M; Jit, M;
2026
PLOS global public health, (2026).6 7 10.1371/journal.pgph.0006731.
Global, regional, and national impact of the Expanded Programme on Immunization against 14 pathogens from 1974 to 2024: an economic evaluation.
Lai, X; ABBAS, K; Pouwels, KB; Jit, M; Fang, H;
2026
The Lancet global health, (2026).14 7 10.1016/j.langlo.2026.103965.
Public health impact, cost-effectiveness, and budget impact of HPV vaccination in Kazakhstan: a stakeholder engagement and modelling study.
Young, GT B; Kassymova, S; Zhang, P; Syla, S; CLARK, A; Sadykova, T; Sukhanberdiyev, K; ABBAS, K;
2026
Vaccine: X, (2026).31, 10.1016/j.jvacx.2026.100845.
Quantifying relative health impact across Gavi, the Vaccine Alliance's portfolio in 117 countries at the subregional level: a modelling study.
Gaythorpe, KA M; Li, X; Shankar, M; Hartner, A-M; Gibney, Z; ABBAS, K; Abeysuriya, R; Alam, C; Auzenbergs, M; Azman, AS; Barasa, E; Costello, A; Ferrari, MJ; Fraser, K; FU, H; Haile, L; Kakaï, RG; Karachaliou-Prasinou, A; Lee, EC; Katama, EN; Kim, J-H; Jit, M; LIU, Y; Malinga, J; Moore, S; ... Trotter, CL.
2026
The Lancet, (2026).407 10542 10.1016/S0140-6736(26)00555-6.
Economic burden of typhoid fever by antimicrobial resistance in India: a modelling study 2023.
MOGASALE, VV; John, J; Ray, A; Farooqui, HH; Mogasale, V; Hutubessy, R; Dhoubhadel, BG; EDMUNDS, WJ; CLARK, A; ABBAS, K;
2026
The Lancet Regional Health - Southeast Asia, (2026).47, 10.1016/j.lansea.2026.100748.
Impact and cost-effectiveness of maternal vaccine and short and long-acting monoclonal antibodies against respiratory syncytial virus among children in Japan: A modeling study.
Kitamura, N; Kimura, T; Morino, S; Suzuki, M; Cook, AR; ABBAS, K;
2026
Vaccine: X, (2026).30, 10.1016/j.jvacx.2026.100805.
Burden of typhoid fever and antimicrobial resistance in India (2023): a modelling study.
MOGASALE, VV; John, J; Sahai, N; Ray, A; Farooqui, HH; Mogasale, V; Dhoubhadel, BG; EDMUNDS, WJ; CLARK, A; ABBAS, K;
2026
The Lancet Regional Health - Southeast Asia, (2026).44, 10.1016/j.lansea.2025.100714.